Questions about production, distribution and, most importantly, the
performance and capability of the shot itself still need to be
answered, even if the numbers look highly promising, according to
vaccine specialists.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pfizer-vaccine-results-leave-questions-about-safety-longevity/articleshow/79149302.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment